1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Neurocrine

Anonymous board for Neurocrine


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    17
    Views:
    1,966
  2. anonymous
    Replies:
    75
    Views:
    13,905
  3. anonymous
    Replies:
    16
    Views:
    5,102
  4. anonymous
    Replies:
    2
    Views:
    540
  5. anonymous
    Replies:
    3
    Views:
    687
  6. anonymous
    Replies:
    50
    Views:
    6,373
  7. anonymous
    Replies:
    1
    Views:
    779
  8. anonymous
    Replies:
    4
    Views:
    1,232
  9. anonymous
    Replies:
    30
    Views:
    11,458
  10. anonymous
    Replies:
    3
    Views:
    1,409
  11. anonymous
    Replies:
    5
    Views:
    1,656
  12. anonymous
    Replies:
    8
    Views:
    2,333
  13. anonymous
    Replies:
    2
    Views:
    2,337
  14. anonymous
    Replies:
    14
    Views:
    3,894
  15. anonymous
    Replies:
    6
    Views:
    1,048
  16. anonymous
    Replies:
    9
    Views:
    1,537
  17. anonymous
    Replies:
    18
    Views:
    4,108
  18. anonymous
    Replies:
    2
    Views:
    1,144
  19. anonymous
    Replies:
    36
    Views:
    17,582
  20. anonymous
    Replies:
    0
    Views:
    822

Thread Display Options

Loading...